Probeam Proton Therapy System
Payments companies reported to CMS as associated with Probeam Proton Therapy System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Probeam Proton Therapy System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Probeam Proton Therapy System
These are the largest totals companies reported as associated with Probeam Proton Therapy System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jeffrey Bradley | Saint Louis, MO | Radiation Oncology | $178.61 |
| Elizabeth Nichols | Columbia, MD | Radiation Oncology | $161.45 |
| Phuoc Tran | Houston, TX | Radiation Oncology | $161.45 |
| William Regine | Baltimore, MD | Radiation Oncology | $161.45 |
| Matthew Ferris | Bel Air, MD | Radiation Oncology | $161.45 |
| Gordon Abrams | Pittsburgh, PA | Diagnostic Radiology | $112.91 |
| John Perentesis | Cincinnati, OH | Pediatric Hematology-Oncology | $112.91 |
| Charles Simone | Lawrenceville, NJ | Hematology & Oncology | $75.50 |
| Jehee Choi | San Diego, CA | Radiation Oncology | $75.50 |
| Pamela Boimel | Lancaster, PA | Radiation Oncology | $55.04 |
Prescribed Probeam Proton Therapy System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.